Metal Allergy Test Performed Prior to Surgery
May 15, 2013 11:24 am | by National Jewish Health | Videos | CommentsPaula Spurlock was experiencing intense itching following hip replacement surgery. It turned out that she was allergic to the hip implant and the bone cement used to keep the implant in place. Now, a new test can help to prevent this type of problem for future patients who require an orthopedic implant.
ACell MatriStem Technology Ranks Highest in Constructive Remodeling
May 15, 2013 11:01 am | by The Associated Press | News | CommentsACell, Inc., a leading developer of next-generation regenerative medicine products, announced today that its MatriStem medical devices demonstrate the highest constructive remodeling response in a recent study comparing 14 extracellular matrices (ECM) designed to aid in surgical procedures. ...
MiE's PET SCINTRON Receives FDA Approval
May 15, 2013 9:51 am | by Bio-Medicine.Org | News | CommentsHOUSTON , May 15, 2013 /PRNewswire-iReach/ -- Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) are pleased to announce that the ECAT Scintron has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). MiE along with NIS will showcase this product at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Vancouver, BC , Canada Ju...
Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device
May 15, 2013 8:00 am | by The Associated Press | News | CommentsCardica, Inc. (Nasdaq: CRDC) today announced it has completed enrollment in the European clinical study for its MicroCutter XCHANGET 30, a cartridge-based cutting/stapling device with a 5-millimeter shaft diameter and cross-sectional area more than six times smaller than standard...
ApoCell Announces Delivery of First Prototypes of ApoStreamT Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute
May 15, 2013 8:00 am | by The Associated Press | News | CommentsApoCell, Inc. announced that the first prototypes of its ApoStreamT circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million ...
IPG Launches IPG PathFinder 360™, Transforming Healthcare through Cost Transparency
May 15, 2013 8:00 am | by The Associated Press | News | CommentsATLANTA--(BUSINESS WIRE)--May 15, 2013--IPG, the industry leading provider of Device Benefit Management™ (DBM) solutions, announced today the launch of a solution that will drastically transform healthcare through cost transparency. Built on the intelligence and expertise from IPG’s proven DBM...
Southern Denmark Tackles Heart Disease with IBM Big Data Analytics Program
May 15, 2013 5:35 am | by IBM | News | CommentsIBM announced today that the Region of Southern Denmark is launching a new program to provide comprehensive insight to improve the quality and comprehensiveness of care for patients with chronic illness. The goal of the program is to facilitate real-time communication among patients, physicians, pharmacists, mental health professionals and specialists so all parties have insight into patient care plans.
Emphasis on X-Ray Quality Spurs Adoption of Computed and Digital Radiography in Europe, Finds Frost & Sullivan
May 15, 2013 4:07 am | by Bio-Medicine.Org | News | CommentsLONDON , May 15, 2013 /- The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will sustain investments in the European computed and digita...
Mitsubishi Electric Begins Testing New Proton Therapy Technology
May 14, 2013 9:30 pm | by The Associated Press | News | CommentsTOKYO--(BUSINESS WIRE)--May 14, 2013--Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has completed the construction of a new proton therapy system for cancer treatment at its Energy Systems Center in Kobe, Hyogo Prefecture. The company has started testing of the new...
Using Clay to Grow Bone
May 14, 2013 3:10 pm | by Brigham and Women's Hospital | News | CommentsIn new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications
May 14, 2013 3:05 pm | by University of Pittsburgh | News | CommentsAlloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale—producing materials with properties unlike their predecessors.
Medical Device Manufacturer Devon Medical Receives CE Mark for extriCARE® Negative Pressure Wound Therapy (NPWT) System
May 14, 2013 12:30 pm | by The Associated Press | News | CommentsKING OF PRUSSIA, Pa.--(BUSINESS WIRE)--May 14, 2013--Devon Medical, Inc., a global medical device manufacturer, designer, and distributor, announced today it has received the CE mark for its portable extriCARE® 2400 Negative Pressure Wound Therapy (NPWT) system. The CE mark designation will allow...
VESTAKEEP PEEK-Based Spinal Implant Receives FDA 510(k) Approval
May 14, 2013 11:21 am | by Evonik | News | CommentsXiphos™ ALIF, a VESTAKEEP® PEEK-based spinal implant developed by DiFusion Technologies, has received the U.S. Food and Drug Administration’s (FDA) 510(k) approval for use in Interbody Fusion Devices (IBF) devices. “DiFusion Technologies is very excited about the FDA 510(k) approval of the VESTAKEEP® PEEK-based Xiphos™ ALIF spinal implant,” said Derrick Johns, managing director of DiFusion Technologies.
How Can Advanced Imaging Studies Enhance Diabetes Management?
May 14, 2013 10:31 am | by Diabetes Technology & Therapeutics | News | CommentsNew approaches to applying noninvasive imaging tests such as computed tomography, magnetic resonance, and positron emission tomography may play a bigger role in evaluating and managing patients with diabetes. Advances in noninvasive imaging technology can assess important changes in fat composition and distribution in the body that may affect the metabolic complications and diseases associated with diabetes.
UGA Researchers Develop Synthetic HDL Cholesterol Nanoparticles
May 14, 2013 10:28 am | by Alan Flurry, Franklin College of Arts and Sciences | News | CommentsAtherosclerosis, a buildup of cellular plaque in the arteries, remains one of the leading causes of death globally. While high-density lipoprotein, or HDL, the so-called good cholesterol, is transferred to the liver for processing, low-density lipoprotein, or LDL, builds up in the arteries in the form of plaque.
Digital Mammography Cancer Detection Rates May Vary Significantly
May 14, 2013 10:03 am | by Radiological Society of North America | News | CommentsDigital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study published online in the journal Radiology. The findings are the first to show a difference between the two types of digital imaging when compared with screen film mammography and suggest that women should be informed of the potential for lower cancer detection with CR, the researchers said.
Olympus Endoscopes Now Powered by Next-Generation Ultrasound Processor
May 14, 2013 9:12 am | by The Associated Press | News | CommentsOlympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that the Company's ultrasound endoscopes will now be powered by the ProSound F75 Ultrasound Processor.
EndoGastric Solutions® Unveils New Research Demonstrating the Benefits of Transoral Incisionless Fundoplication (TIF®) vs. Maximum PPI Therapy
May 14, 2013 9:00 am | by The Associated Press | News | CommentsREDWOOD CITY, Calif.--(BUSINESS WIRE)--May 14, 2013--EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for Gastroesophageal Reflux Disease (GERD), today announced the presentation of randomized controlled trial data and key educational activities taking place at...
Lieff Cabraser Announces Class Action Litigation Against Intuitive Surgical, Inc.
May 14, 2013 9:00 am | by The Associated Press | News | CommentsSAN FRANCISCO--(BUSINESS WIRE)--May 14, 2013--The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of all persons who purchased or otherwise acquired the securities of Intuitive Surgical, Inc. (“Intuitive” or the “Company”)...
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
May 14, 2013 8:04 am | by PR Newswire | News | CommentsMENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients...
Vocera® Ranked Number One in Wireless Communications for Healthcare
May 14, 2013 8:03 am | by PR Newswire | News | CommentsSAN JOSE, Calif., May 14, 2013 /PRNewswire/ -- Vocera Communications, Inc. (NYSE: VCRA), the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced findings...
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
May 14, 2013 8:00 am | by The Associated Press | News | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--May 14, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced enrollment of the first patient in the EnligHTN III trial. This study will evaluate the safety and performance of the new second-generation EnligHTN ™ Renal...
The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
May 13, 2013 4:30 pm | by PR Newswire | News | CommentsSYDNEY, May 13, 2013 /PRNewswire/ -- The University of Sydney and ResMed Limited today announced a new partnership that includes significant and long-term funding of research at the University, ultimately benefitting the hundreds of millions of sufferers of sleep-disordered breathing worldwide.
A Material Argument: Ceramic Injection Molding
May 13, 2013 3:17 pm | by Dr. Rachael Ambury, Sales and Applications Engineer, Morgan Technical Ceramics. | Morgan Technical Ceramics | Articles | CommentsCeramic injection molded products are increasingly being used in the manufacture of innovative medical components and devices, thanks to the unique range of material and performance attributes. In this article, the material, its key features, and the growing range of applications for which it is suited are highlighted.
Why Medtech Startups Are Moving to Ireland
May 13, 2013 2:33 pm | by Eddie Goodwin, Manager, Boston Office, Enterprise Ireland | Blogs | CommentsIt’s no secret that getting a medical device to market can be a lengthy, frustrating process. Facing the new medical device excise tax and lack of clarity from the FDA around regulatory policies, medtech startups are now starting to rethink launching in the U.S.


